Cargando…
Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD)
BACKGROUND: No previous study has investigated the adherence rate of North-African pulmonologists to the 2017-GOLD PTGs. AIMS: To investigate the adherence rate of Tunisian pulmonologists to the 2017-GOLD PTGs and to identify the barriers to their adherence. METHODS: This was a cohort study involvin...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066397/ https://www.ncbi.nlm.nih.gov/pubmed/32190644 http://dx.doi.org/10.1155/2020/1031845 |
_version_ | 1783505240923832320 |
---|---|
author | Aissa, Sana Knaz, Asma Maatoug, Jihene Khedher, Ahmed Benzarti, Wafa Abdelghani, Ahmed Garrouche, Abdelhamid Hayouni, Abdelaziz Benzarti, Mohamed Gargouri, Imen Ben Saad, Helmi |
author_facet | Aissa, Sana Knaz, Asma Maatoug, Jihene Khedher, Ahmed Benzarti, Wafa Abdelghani, Ahmed Garrouche, Abdelhamid Hayouni, Abdelaziz Benzarti, Mohamed Gargouri, Imen Ben Saad, Helmi |
author_sort | Aissa, Sana |
collection | PubMed |
description | BACKGROUND: No previous study has investigated the adherence rate of North-African pulmonologists to the 2017-GOLD PTGs. AIMS: To investigate the adherence rate of Tunisian pulmonologists to the 2017-GOLD PTGs and to identify the barriers to their adherence. METHODS: This was a cohort study involving clinically stable COPD patients who presented to a pulmonology outpatient consultation. The patients were classified as having been appropriately and inappropriately (over- or undertreatment) treated for the GOLD group. Logistic regression was performed to determine the adherence barriers to the 2017-GOLD PTGs. RESULTS: A total of 296 patients were included (88.1% males, mean age: 68 ± 10 years; GOLD A (7.1%), B (36.1%), C (4.1%), and D (52.7%)). The pulmonologists' adherence rate to the 2017-GOLD PTGs was 29.7%. There was a significant statistical difference between the adherence rates among the four GOLD groups (A: 19.0%, B: 20.6%, C: 8.3%, and D: 39.1%; p = 0.001). Differences were statistically significant between the GOLD group D and groups B (p = 0.001). Differences were statistically significant between the GOLD group D and groups B (p = 0.001). Differences were statistically significant between the GOLD group D and groups B ( CONCLUSION: The adherence rate of Tunisian pulmonologists to the 2017-GOLD PTGs is low. It seems that the patients' age, socioeconomic level, national health insurance coverage, and GOLD groups influenced their adherence. |
format | Online Article Text |
id | pubmed-7066397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-70663972020-03-18 Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD) Aissa, Sana Knaz, Asma Maatoug, Jihene Khedher, Ahmed Benzarti, Wafa Abdelghani, Ahmed Garrouche, Abdelhamid Hayouni, Abdelaziz Benzarti, Mohamed Gargouri, Imen Ben Saad, Helmi Biomed Res Int Research Article BACKGROUND: No previous study has investigated the adherence rate of North-African pulmonologists to the 2017-GOLD PTGs. AIMS: To investigate the adherence rate of Tunisian pulmonologists to the 2017-GOLD PTGs and to identify the barriers to their adherence. METHODS: This was a cohort study involving clinically stable COPD patients who presented to a pulmonology outpatient consultation. The patients were classified as having been appropriately and inappropriately (over- or undertreatment) treated for the GOLD group. Logistic regression was performed to determine the adherence barriers to the 2017-GOLD PTGs. RESULTS: A total of 296 patients were included (88.1% males, mean age: 68 ± 10 years; GOLD A (7.1%), B (36.1%), C (4.1%), and D (52.7%)). The pulmonologists' adherence rate to the 2017-GOLD PTGs was 29.7%. There was a significant statistical difference between the adherence rates among the four GOLD groups (A: 19.0%, B: 20.6%, C: 8.3%, and D: 39.1%; p = 0.001). Differences were statistically significant between the GOLD group D and groups B (p = 0.001). Differences were statistically significant between the GOLD group D and groups B (p = 0.001). Differences were statistically significant between the GOLD group D and groups B ( CONCLUSION: The adherence rate of Tunisian pulmonologists to the 2017-GOLD PTGs is low. It seems that the patients' age, socioeconomic level, national health insurance coverage, and GOLD groups influenced their adherence. Hindawi 2020-02-28 /pmc/articles/PMC7066397/ /pubmed/32190644 http://dx.doi.org/10.1155/2020/1031845 Text en Copyright © 2020 Sana Aissa et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Aissa, Sana Knaz, Asma Maatoug, Jihene Khedher, Ahmed Benzarti, Wafa Abdelghani, Ahmed Garrouche, Abdelhamid Hayouni, Abdelaziz Benzarti, Mohamed Gargouri, Imen Ben Saad, Helmi Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD) |
title | Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD) |
title_full | Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD) |
title_fullStr | Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD) |
title_full_unstemmed | Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD) |
title_short | Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD) |
title_sort | adherence of north-african pulmonologists to the 2017-global initiative for chronic obstructive lung disease (gold) pharmacological treatment guidelines (ptgs) of stable chronic obstructive pulmonary disease (copd) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066397/ https://www.ncbi.nlm.nih.gov/pubmed/32190644 http://dx.doi.org/10.1155/2020/1031845 |
work_keys_str_mv | AT aissasana adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd AT knazasma adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd AT maatougjihene adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd AT khedherahmed adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd AT benzartiwafa adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd AT abdelghaniahmed adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd AT garroucheabdelhamid adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd AT hayouniabdelaziz adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd AT benzartimohamed adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd AT gargouriimen adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd AT bensaadhelmi adherenceofnorthafricanpulmonologiststothe2017globalinitiativeforchronicobstructivelungdiseasegoldpharmacologicaltreatmentguidelinesptgsofstablechronicobstructivepulmonarydiseasecopd |